{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:04:17Z","timestamp":1790845457607,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-0500-5-552","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T16:09:35Z","timestamp":1350403775000},"source":"Crossref","is-referenced-by-count":54,"title":["Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Claudia","family":"Colomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lalicata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Trizzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucina","family":"Titone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Tolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"issue":"9464","key":"1830_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005, 365 (9464): 1054-1061.","journal-title":"Lancet"},{"issue":"17","key":"1830_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005, 352 (17): 1779-1790. 10.1056\/NEJMoa051113.","journal-title":"N Engl J Med"},{"issue":"12","key":"1830_CR3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ajh.22210","volume":"86","author":"A Tefferi","year":"2011","unstructured":"Tefferi A: Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2011, 86 (12): 1017-1026. 10.1002\/ajh.22210.","journal-title":"Am J Hematol"},{"issue":"12","key":"1830_CR4","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1158\/1078-0432.CCR-12-0653","volume":"15","author":"AB Deisseroth","year":"2012","unstructured":"Deisseroth AB, Kaminskas E, Grillo J, Chen W, Saber H, Lu H, Rothmann MD, Brar SS, Wang J, Garnett C, Bullock J, Burke L, Rahman A, Sridhara R, Farrell A: US Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with intermediate and high Risk Myelofibrosis. Clin Cancer Res. 2012, 15 (12): 3212-3217.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1830_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, Stalbovskaya V, McQuitty M, Hunter DS, Levy R, Knoops L, Cervantes F, Vannucchi AM, Barbui T, Barosi G: JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012, 366 (9): 787-798. 10.1056\/NEJMoa1110556.","journal-title":"N Engl J Med"},{"issue":"12","key":"1830_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","volume":"363","author":"S Verstovsek","year":"2010","unstructured":"Verstovsek S, Kantarjian H, Mesa RA, Pardanani AD, Cortes-Franco J, Thomas DA: Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med. 2010, 363 (12): 1117-1127. 10.1056\/NEJMoa1002028.","journal-title":"N Engl J Med"},{"key":"1830_CR7","first-page":"95","volume":"8","author":"A Ostojic","year":"2012","unstructured":"Ostojic A, Vrhovac R, Verstovsek S: Ruxolitinib for the treatment of myelofibrosis: its clinical potential. Ther Clin Risk Manag. 2012, 8: 95-103. Epub 2012 Mar 1","journal-title":"Ther Clin Risk Manag"},{"key":"1830_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol. 1997, 15: 749-795. 10.1146\/annurev.immunol.15.1.749.","journal-title":"Annu Rev Immunol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-5-552\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T16:53:06Z","timestamp":1548089586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1830"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-552","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]},"article-number":"552"}}